Skip to main content
OpenTrials

Clinical trial condition

Cross Infection

Explore clinical trials studying Cross Infection. Study availability and eligibility vary by location and protocol.

326 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Cross Infection trial results

Completed

Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated Pneumonia

NCT02585180

Conditions
Cross Infection, Disease Attributes, Healthcare-Associated Pneumonia, +10 more
Locations
  • CHU André Vésale Montigny-le-Tilleul, Belgium
  • CH Annecy Genevois Annecy, France
  • Centre Hospitalier Victor Dupouy Argenteuil, France
  • Centre Hospitalier Intercommunal des Portes de l'Oise Beaumont-sur-Oise, France
View all 15 locations
View Trial Details
Completed

Impact of the Subglottic Secretions Drainage on the Tracheal Secretions Colonisation

NCT02583308

Conditions
Cross Infection, Disease Attributes, Healthcare-Associated Pneumonia, +10 more
Locations
  • CHU André Vésale Montigny-le-Tilleul, Belgium
  • CH Annecy Genevois Annecy, France
  • Centre Hospitalier Victor Dupouy Argenteuil, France
  • Centre Hospitalier Intercommunal des Portes de l'Oise Beaumont-sur-Oise, France
View all 15 locations
View Trial Details
Completed

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

NCT02714595

Conditions
Bloodstream Infections (BSI), Complicated Urinary Tract Infection (cUTI), Cross Infection, +17 more
Locations
  • Shionogi Research Site Hartford, Connecticut, United States
  • Shionogi Research Site Newark, Delaware, United States
  • Shionogi Research Site Chicago, Illinois, United States
  • Shionogi Research Site New Orleans, Louisiana, United States
View all 85 locations
View Trial Details
Completed

SEPREVEN: a Stepped-wedge Randomised Controlled Trial

NCT02598609

Conditions
Catheter-related Bloodstream Infection (CRBSI) Nos, Cross Infection, Digestive System Diseases, +27 more
Locations
  • CHU Strasbourg Hautepierre Strasbourg, Alsace, France
  • CHU Grenoble Grenoble, Auvergne-Rhône-Alpes, France
  • CHU Lille Jeanne de Flandres Lille, Hauts-de-France, France
  • CHU Caen Caen, Normandy, France
View Trial Details
Completed

Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial

NCT02462590

Conditions
Antibiotic-associated Diarrhea, C-Difficile, Cross Infection, +15 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • St. John's Mercy Medical Center St Louis, Missouri, United States
  • Peter Louheed Center Calgary, Alberta, Canada
  • Foothills Medical Center Calgary, Alberta, Canada
View all 44 locations
View Trial Details
Completed

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

NCT03032380

Conditions
Cross Infection, Disease Attributes, Healthcare-Associated Pneumonia, +12 more
Locations
  • Shionogi Research Site New Haven, Connecticut, United States
  • Shionogi Research Site DeLand, Florida, United States
  • Shionogi Research Site Chicago, Illinois, United States
  • Shionogi Research Site Council Bluffs, Iowa, United States
View all 119 locations
View Trial Details

Related conditions